References
- PaulesCSubbaraoKInfluenzaLancet2017390 697 70810.1016/S0140-6736(17)30129-0
- PetrovaVNRussellCAThe evolution of seasonal influenza virusesNat. Rev. Microbiol.201816476010.1038/nrmicro.2017.118
- PotterCWOxfordJSDeterminants of immunity to influenza infection in manBr. Med. Bull.197935697510.1093/oxfordjournals.bmb.a071545
- MemoliMJEvaluation of antihemagglutinin and antineuraminidase antibodies as correlates of protection in an influenza A/H1N1 virus healthy human challenge modelmBio20167e004170041610.1128/mBio.00417-164959521
- MontoASAntibody to influenza virus neuraminidase: an independent correlate of protectionJ. Infect. Dis.20152121191119910.1093/infdis/jiv195
- World Health Organization.Recommended composition of influenza virus vaccines for use in the 2017-2018 northern hemisphere influenza seasonWkly. Epidemiol. Rec.201792117128
- World Health Organization.Recommended composition of influenza virus vaccines for use in the 2018 southern hemisphere influenza seasonWkly. Epidemiol. Rec.201792625633
- Centre for Health Protection.Local situation of influenza activity (as of Sept 27, 2017)Flu Express20171415
- Tsou, T. P., Su, C. P., Huang, W. T., Yang, J. R., Liu, M. T. Influenza A(H3N2) virus variants and patient characteristics during a summer influenza epidemic in Taiwan, 2017. Eur. Surveill. 22, pii=17-00767 (2017).
- ChambersBSParkhouseKRossTMAlbyKHensleySEIdentification of hemagglutinin residues responsible for H3N2 antigenic drift during the 2014-2015 influenza seasonCell Rep.2015121610.1016/j.celrep.2015.06.0054487778
- DuganVGUpdate: influenza activity - United States, October 1-November 25, 2017MMWR Morb. Mortal. Wkly. Rep.2017661318132610.15585/mmwr.mm6648a25757637
- TrebbienRChanges in genetically drifted H3N2 influenza A viruses and vaccine effectiveness in adults 65 years and older during the 2016/17 season in DenmarkJ. Clin. Virol.2017941710.1016/j.jcv.2017.06.007
- Pebody, R., et al. End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17. Eur. Surveill.22, pii=17-00306 (2017).
- FlanneryBInterim estimates of 2016-17 seasonal influenza vaccine effectiveness - United States, February 2017MMWR Morb. Mortal. Wkly. Rep.20176616717110.15585/mmwr.mm6606a35657861
- WuNCA structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccinePLoS Pathog.201713e100668210.1371/journal.ppat.10066825667890
- ZostSJContemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strainsProc. Natl Acad. Sci. USA2017114125781258310.1073/pnas.17123771145703309
- World Health Organization.Recommended composition of influenza virus vaccines for use in the 2016-2017 northern hemisphere influenza seasonWkly. Epidemiol. Rec.201691121132
- SmithDJMapping the antigenic and genetic evolution of influenza virusScience200430537137610.1126/science.1097211
- KoelBFSubstitutions near the receptor binding site determine major antigenic change during influenza virus evolutionScience201334297697910.1126/science.1244730
- PopovaLImmunodominance of antigenic site B over site A of hemagglutinin of recent H3N2 influenza virusesPLoS ONE20127e4189510.1371/journal.pone.00418953405050
- LongJEvolution of H3N2 influenza virus in a guinea pig modelPLoS ONE20116e2013010.1371/journal.pone.00201303142111
- HuangZZYuLHuangPLiangLJGuoQCharged amino acid variability related to N-glyco -sylation and epitopes in A/H3N2 influenza: Hem -agglutinin and neuraminidasePLoS ONE201712e017823110.1371/journal.pone.01782315510802
- WalkerDLHorsfallFLJr.Lack of identity in neutralizing and hemagglutination-inhibiting antibodies against influenza virusesJ. Exp. Med.195096586
- GuoLHuman antibody responses to avian influenza A(H7N9) virus, 2013Emerg. Infect. Dis.20142019220010.3201/eid2002.1310943901473
- TrueloveSA comparison of hemagglutination inhibition and neutralization assays for characterizing immunity to seasonal influenza AInfluenza Other Respir. Virus20161051852410.1111/irv.12408
- VerschoorCPMicroneutralization assay titres correlate with protection against seasonal influenza H1N1 and H3N2 in childrenPLoS ONE201510e013153110.1371/journal.pone.01315314479562
- LeeACSuboptimal humoral immune response against influenza A(H7N9) virus is related to its internal genesClin. Vaccin. Immunol.2015221235124310.1128/CVI.00443-15
- ChenMISerological response in RT-PCR confirmed H1N1-2009 influenza a by hemagglutination inhibition and virus neutralization assays: an observational studyPLoS ONE20105e1247410.1371/journal.pone.00124742930007
- NachbagauerRDefining the antibody cross-reactome directed against the influenza virus surface glycoproteinsNat. Immunol.20171846447310.1038/ni.36845360498
- Center for Health Protection. Recommendations on Seasonal Influenza Vaccination for the 2017/18 Season. Available at http://www.chp.gov.hk/files/pdf/short_version_of_recommendations_on_seasonal_influenza_vaccination_for_the_2017_18.pdf. Accessed on 30 December 2017.
- NohJYInterim estimates of the effectiveness of the influenza vaccine against A(H3N2) influenza in adults in South Korea, 2016-2017 seasonPLoS ONE201712e017801010.1371/journal.pone.01780105444786
- RobertsonJSStructural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virusVirology1987160313710.1016/0042-6822(87)90040-7
- KatzJMWebsterRGEfficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggsJ. Infect. Dis.198916019119810.1093/infdis/160.2.191
- SkowronskiDMLow 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating virusesPLoS ONE20149e9215310.1371/journal.pone.00921533965421
- HungIFTopical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trialLancet Infect. Dis.20161620921810.1016/S1473-3099(15)00354-0
- ZhangAJHigh incidence of severe influenza among individuals over 50 years of ageClin. Vaccin. Immunol.2011181918192410.1128/CVI.05357-11
- ToKKHigh titer and avidity of nonneutralizing antibodies against influenza vaccine antigen are associated with severe influenzaClin. Vaccin. Immunol.2012191012101810.1128/CVI.00081-12
- LaurieKLInternational laboratory comparison of influenza microneutralization assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) influenza viruses by CONSISEClin. Vaccin. Immunol.20152295796410.1128/CVI.00278-15
- Centre for Health Protection. Statistics on Laboratory Surveillance. Influenza virus subtyping. Available at https://www.chp.gov.hk/en/statistics/data/10/641/643/2275.html. Accessed on 18 December 2017.
- ShuYMcCauleyJGISAID: Global initiative on sharing all influenza data - from vision to realityEur. Surveill.2017223049410.2807/1560-7917.ES.2017.22.13.30494
- ChenYHuman infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genomeLancet20133811916192510.1016/S0140-6736(13)60903-4
- ToKKUnique reassortant of influenza A(H7N9) virus associated with severe disease emerging in Hong KongJ. Infect.201469606810.1016/j.jinf.2014.02.012